Pantoprazole Otc Mylan 20 mg MR tablet
PDF Leaflet Revision Date: 24 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of gastric acid reflux symptoms such as heartburn and acid regurgitation.
Dosage (summary)
One 20 mg tablet daily in the morning; consult a doctor if no relief in 2 weeks.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; use with caution.
Key Drug Interactions
- Atazanavir
- NSAIDs
- Warfarin
- Methotrexate
Contraindications
- Hypersensitivity to pantoprazole
- Severe liver impairment
- Children
Common side effects
- Diarrhoea
- Headache
Counselling Points
- Take before or during breakfast
- Monitor for persistent symptoms
- Report any unusual skin reactions
Serious warnings
- Risk of interstitial nephritis
- Potential for gastric malignancy masking
- Hypomagnesaemia
Important Disclaimer
The Pantoprazole Otc Mylan 20 mg MR tablet professional information leaflet below is the property of Mylan and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
